Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 67 articles:
HTML format
Text format



Single Articles


    January 2018
  1. OTTO M
    Tau CSF proteins for diagnosis but tau PET imaging for AD diagnosis and staging.
    Neurology. 2018 Jan 10. pii: WNL.0000000000004902.
    PubMed     Text format    


    December 2017
  2. LA JOIE R, Bejanin A, Fagan AM, Ayakta N, et al
    Associations between [(18)F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.
    Neurology. 2017 Dec 27. pii: WNL.0000000000004860.
    PubMed     Text format     Abstract available


  3. GONNEAUD J, Arenaza-Urquijo EM, Mezenge F, Landeau B, et al
    Increased florbetapir binding in the temporal neocortex from age 20 to 60 years.
    Neurology. 2017;89:2438-2446.
    PubMed     Text format     Abstract available


    November 2017
  4. GROTHE MJ, Barthel H, Sepulcre J, Dyrba M, et al
    In vivo staging of regional amyloid deposition.
    Neurology. 2017;89:2031-2038.
    PubMed     Text format     Abstract available


  5. VOGEL JW, Varga Dolezalova M, La Joie R, Marks SM, et al
    Subjective cognitive decline and beta-amyloid burden predict cognitive change in healthy elderly.
    Neurology. 2017;89:2002-2009.
    PubMed     Text format     Abstract available


    October 2017
  6. CHETELAT G, Murray ME
    Amyloid PET scan: Staging beyond reading?
    Neurology. 2017 Oct 18. pii: 10.1212/WNL.0000000000004678.
    PubMed     Text format    


  7. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
    Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
    PubMed     Text format     Abstract available


  8. ROBERTS RO, Knopman DS, Syrjanen JA, Aakre JA, et al
    Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004652.
    PubMed     Text format     Abstract available


    September 2017
  9. CHO H, Baek MS, Choi JY, Lee SH, et al
    18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome.
    Neurology. 2017;89:1170-1178.
    PubMed     Text format     Abstract available


  10. LIM YY, Mormino EC
    APOE genotype and early beta-amyloid accumulation in older adults without dementia.
    Neurology. 2017;89:1028-1034.
    PubMed     Text format     Abstract available


    August 2017
  11. CHARIDIMOU A, Farid K, Baron JC
    Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004539.
    PubMed     Text format     Abstract available


  12. RAPOSO N, Sonnen JA
    Amyloid-PET in cerebral amyloid angiopathy: Detecting vascular amyloid deposits, not just blood.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004548.
    PubMed     Text format    


  13. MOSCONI L, Berti V, Quinn C, McHugh P, et al
    Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004425.
    PubMed     Text format     Abstract available


  14. NEDELSKA Z, Przybelski SA, Lesnick TG, Schwarz CG, et al
    1H-MRS metabolites and rate of beta-amyloid accumulation on serial PET in clinically normal adults.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004421.
    PubMed     Text format     Abstract available


  15. SMITH R, Scholl M, Widner H, van Westen D, et al
    In vivo retention of 18F-AV-1451 in corticobasal syndrome.
    Neurology. 2017;89:845-853.
    PubMed     Text format     Abstract available


    July 2017
  16. RAPOSO N, Planton M, Peran P, Payoux P, et al
    Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004228.
    PubMed     Text format     Abstract available


  17. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Text format     Abstract available


  18. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Text format     Abstract available


    June 2017
  19. BUCKLEY RF, Schultz AP, Hedden T, Papp KV, et al
    Functional network integrity presages cognitive decline in preclinical Alzheimer disease.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004059.
    PubMed     Text format     Abstract available


    May 2017
  20. VANNINI P, Hanseeuw B, Munro CE, Amariglio RE, et al
    Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden.
    Neurology. 2017;88:1759-1767.
    PubMed     Text format     Abstract available


    April 2017
  21. LI Y, Kang W, Yang Q, Zhang L, et al
    Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases.
    Neurology. 2017;88:1493-1500.
    PubMed     Text format     Abstract available


  22. NG KP, Pascoal TA, Mathotaarachchi S, Chung CO, et al
    Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003916.
    PubMed     Text format     Abstract available


    March 2017
  23. DASILVA AF, Nascimento TD, Jassar H, Heffernan J, et al
    Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003861.
    PubMed     Text format     Abstract available


  24. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Text format     Abstract available


  25. PAPP KV, Rentz DM, Mormino EC, Schultz AP, et al
    Cued memory decline in biomarker-defined preclinical Alzheimer disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003812.
    PubMed     Text format     Abstract available


    February 2017
  26. CHASSOUX F, Artiges E, Semah F, Laurent A, et al
    18F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003714.
    PubMed     Text format     Abstract available


  27. LOCKHART SN, Ayakta N, Winer JR, La Joie R, et al
    Elevated 18F-AV-1451 PET tracer uptake detected in incidental imaging findings.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003724.
    PubMed     Text format    


  28. FRANZMEIER N, Duering M, Weiner M, Dichgans M, et al
    Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003711.
    PubMed     Text format     Abstract available


  29. KREISL WC, Lawrence R, Page E, Teich AF, et al
    11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003693.
    PubMed     Text format    


  30. GROTHE MJ, Villeneuve S, Dyrba M, Bartres-Faz D, et al
    Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.
    Neurology. 2017;88:569-576.
    PubMed     Text format     Abstract available


    January 2017
  31. SPINA S, Schonhaut DR, Boeve BF, Seeley WW, et al
    Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations.
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003636.
    PubMed     Text format     Abstract available


  32. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Text format     Abstract available


  33. THOMAS AJ, Attems J, Colloby SJ, O'Brien JT, et al
    Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
    Neurology. 2017;88:276-283.
    PubMed     Text format     Abstract available


    November 2016
  34. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Text format     Abstract available


    October 2016
  35. KIKUCHI A, Okamura N, Hasegawa T, Harada R, et al
    In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
    Neurology. 2016 Oct 28. pii: 10.1212/WNL.0000000000003375.
    PubMed     Text format     Abstract available


  36. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Text format     Abstract available


    September 2016
  37. MATTSSON N, Zetterberg H, Janelidze S, Insel PS, et al
    Plasma tau in Alzheimer disease.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003246.
    PubMed     Text format     Abstract available


  38. VAUGHAN DN, Rayner G, Tailby C, Jackson GD, et al
    MRI-negative temporal lobe epilepsy: A network disorder of neocortical connectivity.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003289.
    PubMed     Text format     Abstract available


  39. GUROL ME, Becker JA, Fotiadis P, Riley G, et al
    Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.
    Neurology. 2016 Sep 7. pii: 10.1212/WNL.0000000000003197.
    PubMed     Text format     Abstract available


    August 2016
  40. BURNHAM SC, Rowe CC, Baker D, Bush AI, et al
    Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up.
    Neurology. 2016 Aug 17. pii: 10.1212/WNL.0000000000003094.
    PubMed     Text format     Abstract available


  41. WALKER Z, Moreno E, Thomas A, Inglis F, et al
    Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.
    Neurology. 2016 Aug 10. pii: 10.1212/WNL.0000000000003076.
    PubMed     Text format     Abstract available


    July 2016
  42. CAVALLARO T, Klunk W
    PiB-PET detects transthyretin-related cerebral amyloid angiopathy.
    Neurology. 2016 Jul 27. pii: 10.1212/WNL.0000000000003018.
    PubMed     Text format    


  43. KNOPMAN DS, Jack CR Jr, Wiste HJ, Weigand SD, et al
    Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.
    Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002979.
    PubMed     Text format     Abstract available


  44. MORMINO EC, Sperling RA, Holmes AJ, Buckner RL, et al
    Polygenic risk of Alzheimer disease is associated with early- and late-life processes.
    Neurology. 2016 Jul 6. pii: 10.1212/WNL.0000000000002922.
    PubMed     Text format     Abstract available


  45. GOTTESMAN RF, Schneider AL, Zhou Y, Chen X, et al
    The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE.
    Neurology. 2016 Jul 1. pii: 10.1212/WNL.0000000000002914.
    PubMed     Text format     Abstract available


    June 2016
  46. CHO H, Choi JY, Hwang MS, Lee JH, et al
    Tau PET in Alzheimer disease and mild cognitive impairment.
    Neurology. 2016 Jun 29. pii: 10.1212/WNL.0000000000002892.
    PubMed     Text format     Abstract available


    May 2016

  47. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
    Neurology. 2016;86:2116.
    PubMed     Text format    


  48. VASSILAKI M, Aakre JA, Mielke MM, Geda YE, et al
    Multimorbidity and neuroimaging biomarkers among cognitively normal persons.
    Neurology. 2016;86:2077-84.
    PubMed     Text format     Abstract available


  49. WERNER P, Saur D, Mildner T, Moller H, et al
    Combined PET/MRI: Multimodality insights into acute stroke hemodynamics.
    Neurology. 2016;86:1926-7.
    PubMed     Text format    


  50. VOEVODSKAYA O, Sundgren PC, Strandberg O, Zetterberg H, et al
    Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Neurology. 2016;86:1754-61.
    PubMed     Text format     Abstract available


    April 2016
  51. INSEL PS, Mattsson N, Mackin RS, Scholl M, et al
    Accelerating rates of cognitive decline and imaging markers associated with beta-amyloid pathology.
    Neurology. 2016 Apr 15. pii: 10.1212/WNL.0000000000002683.
    PubMed     Text format     Abstract available


    March 2016
  52. LIM YY, Laws SM, Villemagne VL, Pietrzak RH, et al
    Abeta-related memory decline in APOE epsilon4 noncarriers: Implications for Alzheimer disease.
    Neurology. 2016 Mar 30. pii: 10.1212/WNL.0000000000002604.
    PubMed     Text format     Abstract available


  53. LANDAU SM, Horng A, Fero A, Jagust WJ, et al
    Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
    Neurology. 2016 Mar 11. pii: 10.1212/WNL.0000000000002576.
    PubMed     Text format     Abstract available


  54. SCOTT G, Ramlackhansingh AF, Edison P, Hellyer P, et al
    Amyloid pathology and axonal injury after brain trauma.
    Neurology. 2016;86:821-8.
    PubMed     Text format     Abstract available


    February 2016
  55. ROUSSAKIS AA, Politis M, Towey D, Piccini P, et al
    Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias.
    Neurology. 2016 Feb 26. pii: 10.1212/WNL.0000000000002494.
    PubMed     Text format     Abstract available


  56. VERA JH, Guo Q, Cole JH, Boasso A, et al
    Neuroinflammation in treated HIV-positive individuals: A TSPO PET study.
    Neurology. 2016 Feb 24. pii: 10.1212/WNL.0000000000002485.
    PubMed     Text format     Abstract available


  57. MARNANE M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, et al
    Periventricular hyperintensities are associated with elevated cerebral amyloid.
    Neurology. 2016;86:535-43.
    PubMed     Text format     Abstract available


    January 2016
  58. NERRANT E, Fourcade C, Coulette S, Lechiche C, et al
    Teaching NeuroImages: Extensive vasogenic edema in Bickerstaff brainstem encephalitis.
    Neurology. 2016;86:e38-9.
    PubMed     Text format    


  59. RUSSELL DS, Jennings DL, Barret O, Tamagnan GD, et al
    Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
    Neurology. 2016 Jan 22. pii: 10.1212/WNL.0000000000002391.
    PubMed     Text format     Abstract available


  60. STOESSL AJ
    Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
    Neurology. 2016;86:228.
    PubMed     Text format    


  61. DEL CAMPO N, Payoux P, Djilali A, Delrieu J, et al
    Relationship of regional brain beta-amyloid to gait speed.
    Neurology. 2016;86:36-43.
    PubMed     Text format     Abstract available


    December 2015
  62. PAYER DE, Guttman M, Kish SJ, Tong J, et al
    D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002285.
    PubMed     Text format     Abstract available


  63. LOHLE M, Mende J, Wolz M, Beuthien-Baumann B, et al
    Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002286.
    PubMed     Text format     Abstract available


    November 2015
  64. CANOSA A, Pagani M, Cistaro A, Montuschi A, et al
    18F-FDG-PET correlates of cognitive impairment in ALS.
    Neurology. 2015 Nov 20. pii: 10.1212/WNL.0000000000002242.
    PubMed     Text format     Abstract available


  65. CHRISTENSEN S, Obi C, Albers G, Lansberg M, et al
    Ultra-acute CT perfusion imaging: A stroke in the scanner.
    Neurology. 2015;85:1725-6.
    PubMed     Text format    


    September 2015
  66. LEE DH, Oh JS, Ham JH, Lee JJ, et al
    Is normosmic Parkinson disease a unique clinical phenotype?
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000001999.
    PubMed     Text format     Abstract available


    July 2015
  67. BREITNER JC
    Yet another "disconnect" between amyloid and Alzheimer disease?
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001871.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: